Semaglutide

Semaglutide (GLP-1 Analog)

GLP-1 receptor agonist used in metabolic and weight management protocols under physician supervision.

Purity

99.1%

Form

Lyophilized Powder

CAS Number

910463-68-2

Storage

-20°C, protected from light

Overview

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to native GLP-1. The C18 fatty diacid chain enables albumin binding, extending the half-life to approximately 7 days. Used in clinical metabolic protocols for glycemic control and weight management under licensed physician supervision.

Research Applications

Metabolic syndrome management

Weight management protocols

Glycemic control

Cardiovascular risk reduction

Non-alcoholic fatty liver disease research

Technical Specifications

Molecular FormulaC187H291N45O59

Molecular Weight4113.58 g/mol

CAS Number910463-68-2

Sequence34-amino acid GLP-1 analog with C18 fatty diacid chain

AppearanceWhite to off-white lyophilized powder

ReconstitutionBacteriostatic water

Storage-20°C, protected from light

COA Available

Lot-specific Certificate of Analysis available upon request for all approved wholesale accounts. Includes HPLC and mass spectrometry data.

Request COA

Quality Standards

GMP-certified synthesis

Independent HPLC verification

Mass spectrometry confirmed

Lot-specific documentation

Wholesale Inquiry

Available to licensed medical providers only. Submit credentials to receive pricing and availability.

Request Access

Related Compounds — GLP-1 Receptor Agonists

Tirzepatide

Tirzepatide (GIP/GLP-1 Dual Agonist)

99.2%View

Retatrutide

Retatrutide (GIP/GLP-1/Glucagon Triple Agonist)

99.0%View

Cagrilintide + Semaglutide

Cagrilintide + Semaglutide Combination (CagriSema)

99.0%View